跳到主要內容

Kumar Neil 的 Form 4 申報

BridgeBio Pharma, Inc.(BBIO),2026/2/12 申報

申報編號
0001470831-26-000118
申報時間
2026/2/12
交易日
2026/2/10-2/11
申報延遲
2 天
10b5-1 計畫
有勾選

這份申報列了 12 筆非衍生性交易。公開市場賣出合計 $574.9 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Kumar NeilCIK 0001742485董事、高階主管(執行長)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2026/2/10Common StockS賣出處分−14,201$71.80F2−$1,019,631.8701,485間接
2026/2/10Common StockS賣出處分−5,799$72.28F4−$419,151.72695,686間接
2026/2/10Common StockS賣出處分−14,040$71.80F5−$1,008,0724,504,407間接
2026/2/10Common StockS賣出處分−5,960$72.27F6−$430,729.24,498,447間接
2026/2/11Common StockS賣出處分−7,806$70.69F7−$551,806.14687,880間接
2026/2/11Common StockS賣出處分−3,716$71.44F8−$265,471.04684,164間接
2026/2/11Common StockS賣出處分−4,484$72.64F9−$325,717.76679,680間接
2026/2/11Common StockS賣出處分−3,994$73.25F10−$292,560.5675,686間接
2026/2/11Common StockS賣出處分−7,860$70.70F7−$555,7024,490,587間接
2026/2/11Common StockS賣出處分−3,775$71.46F11−$269,761.54,486,812間接
2026/2/11Common StockS賣出處分−4,404$72.65F12−$319,950.64,482,408間接
2026/2/11Common StockS賣出處分−3,961$73.25F13−$290,143.254,478,447間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

Represents the weighted average sale price of the shares sold from $71.08 to $72.06 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F4

Represents the weighted average sale price of the shares sold from $72.08 to $72.55 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F5

Represents the weighted average sale price of the shares sold from $71.02 to $72.01 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F6

Represents the weighted average sale price of the shares sold from $72.02 to $72.56 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F7

Represents the weighted average sale price of the shares sold from $70.09 to $71.08 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

表 I 有 2 筆交易的價格引用這則附註。

F8

Represents the weighted average sale price of the shares sold from $71.09 to $72.08 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F9

Represents the weighted average sale price of the shares sold from $72.09 to $73.08 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F10

Represents the weighted average sale price of the shares sold from $73.09 to $73.51 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F11

Represents the weighted average sale price of the shares sold from $71.1 to $72.09 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F12

Represents the weighted average sale price of the shares sold from $72.1 to $73.09 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F13

Represents the weighted average sale price of the shares sold from $73.1 to $73.4 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)